Soligenix Advances Rare Disease Treatments with Promising Clinical Milestones
June 12, 2025 — Soligenix announces Q1 2025 results & clinical milestones for rare disease treatments, including HyBryte(TM) for CTCL & SGX945 for Behçet’s disease. Learn more.